About us
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with a Research & Development innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We are led by a management team with extensive R&D experience, providing direct guidance to our program teams to rapidly advance our candidates from research through all stages of development. We are headquartered in Boston, Massachusetts.
- Website
- http://www.centessa.com
External link for Centessa Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Type
- Public Company
- Founded
- 2021
Employees at Centessa Pharmaceuticals
Updates
-
In November and December, members of Centessa’s management team will participate in upcoming @Guggenheim Partners, @Jefferies, @Piper Sandler, @Evercore, and @Oppenheimer & Co. Inc. conferences. Read more in our latest press release: https://lnkd.in/eF-DcRZ7
-
This morning, Centessa reported financial results for the third quarter of 2025 and provided updates on its potential best-in-class orexin receptor 2 (OX2R) agonist program. Highlights from today’s release are below, and you can find the full release on our website at: https://lnkd.in/em-b8R-T
-
We’re headed to Minneapolis for a weekend of learning, connection, and community at Narcolepsy Network’s 38th Annual Conference from October 24–26. We’re honored to sponsor this event—stop by our tabletop booth if you’ll be there.
-
-
What a week! 100+ Centessa teammates gathered in Boston for a week filled with learning, listening, connecting—and of course, plenty of fun. We took a deep dive into the science driving our OX2R agonist program and gained invaluable perspective from our patient and physician panel. Another productive team event that brought our mission to life!
-